Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 53 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 10023614

    Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases

    Protagonist Therapeutics, Inc. · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted
  2. US 10022382

    RNA polymerase I inhibitors and uses thereof

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted
  3. US 10017516

    BMP inhibitors and methods of use thereof

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jul 10, 2018 · Expires Jul 5, 2038

    granted
  4. US 10011574

    Glutaminase inhibitors and method of use

    Agios Pharmaceuticals, Inc. · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted
  5. US 10005740

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  6. US 10005777

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  7. US 10006080

    High-selectivity contact activation inhibitor based on infestin-4

    OBSCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU “GEMATOLOGICHESKAYA KORPORATSIYA” · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  8. US 10005735

    Inhibitors of RPN11

    The Regents of the University of California · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  9. US 9999650

    Peptide and peptidomimetic inhibitors

    RA PHARMACEUTICALS, INC. · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted
  10. US 10001485

    Methods for sensitizing a quiescent cancer stem cell to a BCR-ABL inhibitor

    The Regents of the University of California · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted
  11. US 9994613

    Prodrug of an ICE inhibitor

    Vertex Pharmaceuticals Incorporated · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted
  12. US 9994547

    Heteroarylamide inhibitors of TBK1

    Takeda Pharmaceutical Company Limited · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted
  13. US 9987284

    Substituted benzooxadiazole DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  14. US 9988397

    ERK inhibitors

    MSD R&D (China) Co. Ltd. · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  15. US 9981961

    Deoxycytidine kinase inhibitors

    The Regents of the University of California · Granted May 29, 2018 · Expires May 24, 2038

    granted
  16. US 9981944

    GDF-8 inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 29, 2018 · Expires May 24, 2038

    granted
  17. US 9980976

    Use of REDD1 inhibitors to dissociate therapeutic and adverse atrophogenic effects of glucocorticoid receptor agonists

    Northwestern University · Granted May 29, 2018 · Expires May 24, 2038

    granted
  18. US 9981999

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted May 29, 2018 · Expires May 24, 2038

    granted
  19. US 9974796

    Inhibitors of the plasmodial surface anion channel as antimalarials

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 22, 2018 · Expires May 17, 2038

    granted
  20. US 9975878

    Substituted triazine BMI-1 inhibitors

    PTC THERAPEUTICS, INC. · Granted May 22, 2018 · Expires May 17, 2038

    granted
  21. US 9962379

    Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods of use

    United States Government as represented by the Department of Veterans Affairs · Granted May 8, 2018 · Expires May 3, 2038

    granted
  22. US 9962377

    Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

    TAKEDA GMBH · Granted May 8, 2018 · Expires May 3, 2038

    granted
  23. US 9956215

    Methods of treating cancer with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted May 1, 2018 · Expires Apr 26, 2038

    granted
  24. US 9957281

    Benzodiazepine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted May 1, 2018 · Expires Apr 26, 2038

    granted